Progyny, Inc. Common Stock (PGNY) — Analysis Summary
Progyny, Inc. Common Stock (PGNY) has a market cap of $1.98B with year-over-year revenue growth of +10.4%. Net margin stands at 4.5%. The stock trades at a P/E ratio of 25.2.
Key Takeaways
- Revenue changed +10.4% year-over-year
- Net margin of 4.5%
- P/E ratio of 25.2
Compared to other companies in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector, PGNY posted revenue growth of +10.4% and trades at a P/E of 25.2.
Progyny, Inc. Common Stock (PGNY)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Sector
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Employees
856
Headquarters
NEW YORK, NY
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.